Early Use of Remdesivir and Risk of Disease Progression in Hospitalized Patients With Mild to Moderate COVID-19

Clinical Therapeutics(2022)

Cited 19|Views10
No score
Abstract
•Remdesivir confers benefit in COVID-19 patients according to the onset of symptoms.•Early hospitalization may be crucial to improve patients outcome.•Alarming symptoms at home should be evaluated to decide hospital admission.
More
Translated text
Key words
COVID-19,COVID-19 progression,early treatment,remdesivir,SARS CoV-2
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined